If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

By Bhanvi Satija and Christy Santhosh (Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

With the close of 2024 and the launch of a new year, we can take a moment to look back at what was another eventful, successful year for Kenosha County. From fiscal wins to work on addressing ...

Today we've published final guidance for the weight loss medication tirzepatide (mounjaro). It means the phased roll out – set out in our guidance – will begin in 2025. In 2022, the government ...

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the ...